EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • DEM Tri-Cycle Report
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

by Caroline Gregory | Sep 30, 2026 | Journal Club, Thrombosis

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism (Therapy) Castellucci LA, et al. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703. Editorial: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous...
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Archives

Get EMOttawa’s weekly clinical pearls ×
EMOttawa AI Search
EMOttawa AI Search Online
Preview